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This  paper  is  concerned  with  special  effects  which  ketonic  or  hydroxyl 
groups  respectively at  position 6  or  16  in  the  steroid nucleus  exert on  the 
growth of the uterus of the rat. 
It has been known for some time that estriol differs from other estrogenic 
compounds in its influence on growth of the female genital tract.  Curtis and 
Doisy (1)  found that estriol is more potent than estrone in causing opening 
of the vaginal plate of infant rats but is less active in evoking vaginal corni- 
fication. Secondly, whilst estriol in small quantity stimulates uterine growth, 
Dorfman,  Gallagher, and Koch  (2,  3)  observed that a  considerable increase 
of dosage  does not  cause  maximal  growth  of this  structure.  More  recently 
Hisaw,  Velardo, and  Goolsby (4)  have shown that  estriol reduces the effec- 
tiveness  of  estrone  or  estradiol  in  causing  uterine  growth  when  these  ster- 
oids are administered together; this effect is remarkable since here one estro- 
genic substance is  inhibiting  the growth effect of another estrogen. 
Heretofore estriol has  been  considered  to  be a  unique  compound in  pos- 
sessing  these  special  physiologic influences.  It  will  be  demonstrated  in  this 
paper  that  certain  other estrogenic  agents exhibit effects on growth similar 
to those induced by estriol. The common molecular feature of these unusual 
estrogens  is  the  presence of  oxygenated functions at  specific sites,  position 
6  or 16 of the estrane molecule. 
The  present  experiments  were  carried  out  on  hypophysectomized  rats 
maintained on a  ration which is free from growth-promoting steroids to min- 
imize  extraneous growth  factors  both  of  endogenous and  exogenous origin. 
The  steroids  which  were investigated  were  closely related in  structure. 
*This  study  was  aided by  grants  from  the  Jane  Coffin Childs Memorial Fund 
for Medical Research, the American Cancer Society, Inc., on recommendation  of the Com- 
mittee on Growth of the National Research Council, and from the Illinois Division of the 
American Cancer Society,  Inc. 
We  are  indebted to  Anna P.  Charr,  Eustus  Lauagan and  Joseph Yavit  for  tech- 
nical assistance. 
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Methods 
Biological.--Hypophysectondzed albino rats maintained under controlled environmental 
conditions  (5)  were injected  with  steroids according to an unvarying schedule. The rats 
were obtained from the breeder at age 22 days and maintained thereafter  on a synthetic 
diet.  1 Hypophysectomy was performed at age 24 days. The steroids were dissolved in ethyl 
alcohol and diluted with sesame oil to make the final alcoholic concentration  10 per cent. 
When steroids were injected in combination, they were administered in the same solution, 
which was always freshly prepared.  The solution  (0.2 ml.)  was injected  subcutaneously 
for 7 days, beginning at age 38 days; 6 or more rats were tested at each dosage level of every 
compound. The perineum was observed each day for opening of the vaginal plate. Necropsy 
was performed at age 45 days. All rats with body weight above 75 gm. or with weight of 
the spleen above 200 rag. were discarded to avoid the risk of residual pituitary activity from 
incomplete hypophysectomy.  At necropsy, the  spleen, preputial  glands,  vagina,  and the 
uterus were excised, blotted  lightly, and weighed promptly  on a  torsion balance. The ni- 
trogen content of the uterus was determined by a  micro-Kjeldald technique. Histological 
preparations  of the vaginal epithelium were made in each case. 
In studies of inhibition of estrone by other steroids, the statistical  probability,  P, of a 
significant effect was derived from Fisher's (6) table of t values. The results were considered 
statistically  significant when P  values less than 0.05 were obtained for both the weight of 
the uterus and its nitrogen content. 
Clwmieal.--Many of the steroids were obtained from other laboratories.  2 Certain mono- 
functional steroids were synthesized in this laboratory by methods to be described (7) else- 
where:  17-desoxyestradiol, A-16,17-desoxyestradiol,  3-desoxyestradiol-17c~-o1, 3-desoxy- 
estradiol-17~-ol, 3-desoxyestradiol-17-one.  A monofunctional steroid by definition (8)  pos- 
sesses an oxygenated function at either position 3 or position 17 but not at both sites. 
RESULTS 
The weight of  the preputial glands of 34 hypophysectomized rats,  age 45 
days and uninjected with steroids was  9.6  4-  1.4 rag.  None of  the phenolic 
estrogens  caused  an  increment of  weight  of  these  structures.  Furthermore 
the  vestigial prostate  was  not  visible in  any  case. 
In Fig. 2, the growth of the uterus is related to the dosage of phenolic es- 
trogens which differ in number of substituent groups and their state of oxi- 
dation;  the  amount  of  steroids  investigated  covered  a  10,000-fold  range. 
These data form a family of curves with one notable exception--estriol (XX)  8 
has anomalous behavior as described previously (2, 3).  In the related curves 
a  small increment of steroid dosage above the threshold amount results in a 
sharp increase of uterine growth succeeded by a  gentle terrace-like rise until 
1  This diet contains about 18.8 per cent protein. The formula is casein 254 gin.; dextrin 
468 gin.; corn oil 38 gin.; alphace150 gin.; mixed vitamins 10 gin.; salt mixture 40 gin.; oleum 
percomorphum 3 drops;  water  140 cc.; vitamin K  50 rag. 
2 We acknowledge with gratitude generous gifts of compounds used in these experiments 
from Dr.  Max N. Huffman, Oklahoma Institute for Medical Research; Dr. Oscar Winter- 
steiner, The Squibb Institute for Medical Research; Dr. G. C. MueUer, McArdle Institute 
for  Cancer  Research;  Dr.  V.  Prelog, Eidgenossische technische Hochschule, Zurich;  and 
Dr.  A.  Zaffaroui, Syntex,  S.A., Mexico, D.  F. 
a The chemical formulae of the steroids are given in Fig.  1. CHARLES  HUGGINS  AND  ELWOOD  V.  yENSEN  337 
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maximal  growth is attained.  Estrogenic  compounds of  this type will  be re- 
ferred to as unimpeded estrogens and for steroids of this kind the minimal 
daily dosage required to initiate the high growth plateau  (terrace point, TP) 
is stated (Table I). 
In  the  case of estriol the  steep increment of growth  is lacking; instead a 
prolonged gradual increase results from augmented steroid dosage, after uterine 
growth has been initiated, until full size is reached. Estriol and compounds to 
be  identified,  with  similar  physiologic activity,  will  be  designated  impeded 
TABLE I 
Quantitative Effect of Unimpeded Estrogens in Promoting Uterine Growtk 
The terrace point is the lowest amount of steroids causing the steep increment of uterine 
growth to be superseded by the final high plateau of growth. 
No.  Steroid  Terrace point dosage* 
I 
II 
III 
IV 
V 
VI 
VII 
VIII 
IX 
X 
XI 
XII 
XIII 
XIV 
XV 
XVI 
Estradiol-1713 
Estrone 
Equittu 
6-Dehydroestrone 
D-Equilenin 
4-Hydroxyestmdiol-i  7fl 
7-Ketoestrone 
Estradiol-17o~ 
1  7-Desoxyestradiol 
Estrone-16 
A-16,17-Desoxyestradiol 
16-Ketoestradiol-17/3 
3-Desoxyestradiol-17fl 
3-Desoxyestrone 
3-Desoxyestradiol-17a 
16-Ketoestrone 
0.025 
0.25 
0.25 
2.5 
5 
10 
10 
10 
10 
10 
20 
25 
25 
5O 
100 
>100 
* This amount was administered daily for 7 days. 
estrogens.  Mter  a  moderate  increase  of uterine  weight  (about  one-third  of 
maximal growth) has been induced by steroids in this class, a tenfold increase 
of dosage causes little or no increment of growth. 
State  of Oxidation  of Unimpeded  Estrogens in Relation  to  Uterine Growth.-- 
Estradiol-17/3 (I) was the most efficient of the unimpeded estrogens (Table I). 
The lack of either of its hydroxyl groups weakened its activity but to an un- 
equal  extent;  17-desoxyestradiol  (IX)  was  more  efficient as  a  promoter  of 
growth  than  3-desoxyestradiol-17/3 (XIII)  which  in  turn  was  more efficient 
than 3-desoxyestrone (XIV)  or 3-desoxyestradiol-17a  (XV).  In accord  with 
earlier findings (9) oxidation of the 17-hydroxyl group of estradiol-17/3 to form 
estrone (II) reduces the activity by a factor of 10. CHARLES  HUGGINS AND  ELWOOD  V,  J'ENSEN  339 
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The presence  of 2  hydrogen atoms at  C6 appears  to be  required for full 
physiologic activity of estrone. No loss of efficiency of estrone occurs when the 
molecule is unsaturated at positions 7 or 8 as in equilin (III) but a consider- 
able decrease of activity follows the removal of a hydrogen atom from the C6 
and  C7 positions of estrone as in 6-dehydroestrone (IV).  No  significant de- 
crease of activity of 6-dehydroestrone results from the introduction of addi- 
tional unsaturatiou in ring B  as in D-equilenin (V). 
i  I  i  I  i  I  I  I  I  '  1  '  I  I  J  I  i  I  I 
I00  -  .o.-',~o  i  Ho..,c~.,.j  /~ 
•  H O/~f~..~  H  0 
I  I  I  I  ,,,,I  ,  ,  ,  I  ,,,, 
0.1  1.0  ~O./  DAY  I0.0 
FIo. 3. Relationship of dosage to uterine weight of 3 impeded estrogens (curves 1, 2, 
3) contrasted with 2 unimpeded estrogenic compounds (curves 4, 5). Ordinates: weight of 
the  uterus in  milligrams. Abscissae: daily  dosage of  steroids in  micrograms plotted 
logarithmically. 
The  introduction of a  ketonic group  at  Cle  in  estradiol-17fl to  form  16- 
ketoestradiol-17~  (XII)  decreases  its  activity  profoundly.  Similarly  16- 
ketoestrone (XVI) is less  than one-thousandth as efficient as estrone in pro- 
rooting growth. Confirming earlier work, introduction of a  4-hydroxyl group 
as in 4-hydroxyestradiol-17fl (VI)  causes a  marked decrease in potency (10) 
and  2-hydroxyestradiol-17~  (XVII)  is  inactive  (11). 
The Impeded Estrogens.--The relationship between the dosage of impeded 
estrogens and the growth response of the uterus is shown in Figs. 2 and 3. 
The compounds recognized as impeded estrogens have either a  ketone group 
at position 6 or a  hydroxyl group at position 16; they are 
1,3,5(10)-estratriene- 
3,17-diol-6-one (6-ketoestradiol-17fl (XIX)) 
3-ol-6,17-dione (6-ketoestrone (XVIII)) 
3,16a-17~-triol (estriol (X,X)) CHARLES  HUGGINS  AND ELWOOD  V. JENSEN  341 
3,16/3,17/3-triol  (16-ep/estriol  (XXI)) 
3,16or, 17ot-triol (17-epbestriol (XXII)) 
3,16~-diol (estradiol-16o~ (XXIII)) 
3,16fl-diol(estradiol-16t3 (XXIV)) 
In earlier studies it has been reported that 17-ep/estriol  (12), estradioM6a, 
estradiol-16fl  (13)  and  6-ketoestradiol-1713  (14)  are  estrogenic but  their  simi- 
larity  to  estriol  was  not  observed. 
A  close similarity was observed in the slope of the curves of uterine growth 
and in the quantities  of all of the impeded estrogens required  to produce this 
TABLE II 
Inkibit~  of Estrone-Induced  Uterine Growth by  Supplementary  Steroids 
Effects on Weight and Nitrogen Content of the Uterus 
In all cases estrone 0.5 ~ug. was administered daily. A indicates the change induced by the 
added steroid. 
Added steroid 
Estriol 
16-Ep/estriol 
t7-P.p/es~ol 
Estradin1-16o~ 
Estradiol-16fl 
~-Ketoestrone 
~Ketoestradiol 
•dthnal  ose 
/~g, 
2.5 
2.5 
2.5 
5.0 
5.0 
5.0 
1.0 
Uterine weight 
Estrone  Estrone -I- 
added 
alone  steroid 
rag.  mg. 
155  4-  30  103  4-  9 
144 4- 30  86 4-  12 
137  4-  21  95  4-  10 
153  4-  30  96  4-  4 
172  4-  20  128  4-  28 
166 4-  28  95  4-  33 
131  4-  14  90  4-  13 
per  ~ 
--33 
--40 
--31 
--37 
-26 
--43 
--32 
Nitrogen content 
Estrone  Estrone + 
alone  added steroid 
rag.  rag. 
3.7  -4- 0.4  2.4 4-  0.3 
3.4 4- 0.5  2.2  4-  0.2 
3.4 4- 0.5  2.4 4-  0.2 
3.7  4- 0.4  2.3  4-  0.3 
4.2  4- 0.5  3.1  4-  0.7 
4.0 4- 0.6  2.3  4-  0.7 
3.3  4- 0.3  2.3  4-  0.3 
-35 
-37 
-29 
-38 
-26 
-42 
-28 
4- indicates standard deviation. 
The P values in each case were less than 0.01 except for estradiol-16O for which the value 
was 0.05. 
growth.  In contrast  to the  foregoing steroids  with  oxygen functions at  posi- 
tions  6  or  16,  it  was  found  that  4-hydroxyestradiol-17fl  and  7-ketoestrone 
(VII) are unimpeded estrogens (Fig. 3). Furthermore 16-ketoestradiol-17fl and 
16-ketoestrone  do  not  cause  an  impeded  growth  response. 
Inhibition of Estrone-Induced Uterine Growth by Impeded Estrogens.--When 
administered  simultaneously  with  estrone,  all  the  impeded  estrogens  tested 
caused a  moderate depression of uterine growth below that induced by estrone 
alone. In this experiment various phenolic estrogens were added to a  constant 
large  quantity  of  estrone,  0.5  /~g. daily--an  amount  which  induced  nearly 
maximal uterine  growth and  which  was considerably larger  than  the  terrace 
point  dosage  of estrone.  The  depression  of uterine  growth  manifested  itself 
both  in  a  decrease of weight and of total  nitrogen content  (Table II) of this 342  IMPEDED ESTROGENS 
organ.  Only partial blockade of the estrone effect was achieved; the maximal 
inhibition of uterine growth was 26 to 43 per cent. In the inhibition of estrone- 
induced  uterine  growth  by phenolic  estrogens  critical  quantities  (stated  in 
Table II)  of the blocking agent  are  involved.  An increase of  the  inhibitor 
above the critical range resulted in renewed growth of the uterus (Fig.  4) ob- 
viously from the estrogenic properties of the inhibitor  itself. 
[I  I  1  I 
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1~o.  4.  The effect of increasing amounts  of  15-elY/estrio] administered  with a  constant 
daily amount of estrone (0.5 #g.)  on the weight (  )  and nitrogen content  (-- -  - -) 
of the uterus. The 2 upper curves indicate  the  effect of  the  combination  of  estrone  and 
15-ep/estriol; the 2 lower curves indicate growth induced by 15-el~/estriol alone.  Ordinates: 
left, uterine weight in m~11igrams; right, nitrogen content of uterus in milligrams. Abscissae: 
daily dosage  of  15-ep/estriol. 
Whereas partial inhibition of the growth-promoting effect of estrone on the 
uterus  was achieved,  no  depression of estrogenic effects on  the vagina  was 
observed. The time of opening of the vaginal plate, induced by estrone, was 
never  retarded  by estriol  or  related  inhibiting  compounds.  Moreover,  the 
weight of the vagina and  the amount of comification estimated from histo- 
logical  sections were not  decreased by estrogenic inhibitors. 
The following unimpeded estrogens failed to inhibit the growth-promoting 
action of estrone: estrone-16  (X); 2-hydroxyestradiol-17j3;  4-hydroxyestradiol- CHARLES  HUGGINS  AND  ELWOOD  V. /ENSEN  343 
17fl;  7-ketoestrone;  16-ketoestradiol-17fl;  estradiol-17a  (VIII);  17-desoxy- 
estradiol; 3-desoxyestradiol-17a; 3-desoxyestradiol-17~. 
Although estriol caused a  significant  depression  of estrone-induced uterine 
growth, it did not inhibit the growth promoting effects of testosterone on the 
uterus (Fig. 5). 
MG. 
150 
I00 ? 
OH  OH 
.w  _w~-- 
H 
I  I  I  I  I  ESTRIOL  I 
0  .2.5  1.0  2.5  ~6.1 DAY  5.0 
FIo. 5.  Failure of estriol to inhibit growth of the uterus induced by testosterone,  i  rag. 
daily. The upper curve shows the effect of testosterone plus estriol on uterine weight; the 
lower  curve  indicates  the  increase  of  uterine  weight  caused  by  estriol  alone.  Ordi- 
nates:  uterine weight in  milligrams. Abscissae: the daily dosage  of estriol in micrograms. 
DISCUSSION 
The impeded estrogens comprise a small group of steroids which differ from 
the majority of estrogenic  compounds in  2 physiologic  activities.  Although 
full growth of the uterus can be evoked by sufficiently large doses of impeded 
estrogens,  the slope of the curve of increment  of uterine weight in response 
to  increased  dosage of these  compounds is  very gradual  rather  than  steep. 
Secondly,  impeded  estrogens  can  partially  inhibit  the  growth-promoting 
effects of estrone.  The impeded estrogens are steroids which possess oxygen- 
ated groups at special  sites,  position 6 or 16. The explanation of the physio- 
logic influences  of impeded estrogens requires consideration of the molecular 
structure of estrane derivatives in terms of its effect on growth. 
In general  the structural  requirements of growth-promoting steroids in the 344  IMPEDED  ESTROGENS 
estrane series  include:  (a)  the site and  (b) number of functional groups,  (c) 
their  steric orientation,  and  (d)  the state of oxidation at select positions of 
the steroid nucleus. 
Members of the estrane series are powerful stimulators of growth when they 
bear oxygenated functions (especially  hydroxyl groups) at specific sites of the 
carbon skeleton, which thereby become active centres. The active centres are 
positions 3, 17, and 16 but they are not equivalent in promoting growth. The 
phenolic hydroxyl is considerably more effective than  the highly active 178- 
alcoholic  hydroxyl  in  exciting  uterine  growth;  thus  17-desoxyestradiol  was 
more effective in  this  regard  than  3-desoxyestradiol-17~.  The  17~-hydroxyl 
group in the androstane series has been shown (8)  to be an active centre in 
eliciting  growth of the uterus and it exerts a similar  effect in the estrane ster- 
oids.  A hydroxyl group in the a-orientation at C17 is devoid of influences  on 
growth, estradiol-17a and  17-desoxyestradiol  had identical effects on uterine 
growth.  The alcoholic  hydroxyl in the ~  orientation at C17 adds to the effec- 
tiveness of the phenolic hydroxyl in promoting growth.  A  third  oxygenated 
group supplementary to those at Ca and  C17 always weakened the quantita- 
tive efficiency of the parent compound in its growth effects.  It was found in 
the present studies that  additional  oxygenated groups  at  C~,  C+,  C6,  C7, or 
C1+  lessened  or  destroyed  the  growth  effects of  estradiol-17~.  It  has  been 
shown  (5)  that  the uterine growth stimulation induced by testosterone also 
is  affected adversely by supplementary hydroxyls at positions 2  (a or ~), 6 
(8), and 11 (a or 8).4 It appears that certain effects of supplementary groups 
at C16 are related to their influence on oxidation of the 17 (8) hydroxyl group. 
An oxygenated group at position  16 can exert two opposite effects on the 
growth process--it can serve as an active center in promoting uterine growth 
or under other circumstances it can retard growth; these opposite effects de- 
pend on the state of oxidation of the supplementary group at C~6 and on the 
presence, nature, and orientation of the substituent at C17. 
The  growth efficiency is enhanced somewhat when a hydroxyl group (a or 
8) is supplied at position 16 of those estrane compounds with no group or an 
a-hydroxyl at C~7. Hydroxylation at position 16 lowers  the threshold dosage 
required for initiating  growth by these steroids although  they are converted 
to impeded estrogens.  In this regard the impeded estrogens, estradiol-16a and 
estradiol-16~,  began to induce uterine growth in lower dosage than  the un- 
impeded  compound,  17-desoxyestradiol;  similarly  17-epiestriol  has  a  lower 
threshold effect on growth than  estradiol-17a. 
However, in the presence of a E-oriented hydroxyl group at C~7, a profound 
i More  recently we  have  found  that  the following testosterone  derivatives, at  a  daily 
dosage of 1 rag, fail to induce growth of the uterus: 8fl-hydroxytestosterone; 14ct-hydroxy- 
testosterone;  15-hydroxytestosterone;  15a-hydroxytestosterone. CHARLES HUGGINS AND  ELWOOD  %r. ~ENSEN  345 
decrease  of  growth-promoting  activity  results  from  an  adjacent  hydroxyl 
group at C16; both estriol and  16-ep/estriol  are less active in exciting uterine 
growth  than  estradiol-17/~. Likewise,  the presence of a  ketone group  at  C16 
decreases the efficiency of estrane compounds with ketone or hydroxyl groups 
at  position  17;  16-ketoestrone  and  16-ketoestradiol-17~  are weak estrogens. 
Such  effects are  reminiscent  of the  influence  of an  oxygenated function  at 
C16 upon the oxidation of the 17/~-hydroxyl group by a highly purified  enzyme 
of bacterial origin,  the/~-steroid dehydrogenase of Talalay and Dobson (15). 
The  bacterial  enzyme  can  oxidize  the  17/~-hydroxyl  group  of estradiol-17~ 
but this  dehydrogenation does not occur when estriol or 16-ketoestradiol-17fl 
are employed as substrates. 
Other  evidence was gathered  that  atoms  bonded  to Ce or C16  are highly 
significant  in the promotion of growth. The loss of one of the hydrogen atoms 
at C6 results in a  considerable decrease of growth activity; 6-dehydroestrone 
is less active than estrone in exciting growth. This indicates an important re- 
lationship  of hydrogen atoms to specific carbon sites in the steroid nucleus, 
since  a  hydrogen atom is dispensible  at positions 7,  8,  or 9 without  change 
in  the  growth  activity  of  the  unsaturated  compound.  Similarly  hydrogen 
atoms at position 16 are involved in the excitation of growth; A-16,17-desoxy- 
estradiol  (XI)  was found to be less efficient  than  17-desoxyestradiol  in  pro- 
moting growth, confirming  earlier  findings  (12). 
The  similarity  of the quantitative  relationship  of dosage to  the resultant 
uterine  growth  of all  the  impeded  estrogens,  irrespective  of the site of the 
supplementary function at C6 or C16, suggests a  common biochemical mech- 
anism to explain  their unusual  influences on growth. We postulate that  both 
the inhibition  of estrone action and  impeded uterine  growth  are related  to 
interaction of oxygenated functions at special  centers of the estrane molecule 
with  a  specific surface possessing  critical  import  in  promoting  growth;  this 
interaction possibly is related to the binding of the steroids to a protein sur- 
face. It is known that phenolic estrogens, such as estrone (16)  and estradiol- 
178 (17), can bind firmly to serum and hepatic liver proteins. Similarly,  con- 
geners  of the 1,3,5  (10)-estratrien-3-ol  family have a  strong affinity (18) for 
the surface of the/~-steroid dehydrogenase of Talalay and Dobson (15). This 
hypothesis would implicate oxygenated groups at positions 6 and  16 as sig- 
nificant loci in the estrane molecule in the binding process.  In this regard no 
inhibition of estrone-stimulation or impedance results when a hydroxyl group 
at C~ or a ketonic group at C7 is added to estradiol-l?/i 
The inhibition of estrone-induced growth by impeded estrogens appears to 
be restricted  to  the  uterus.  Under  conditions  in  which  uterine  growth  was 
depressed,  no  decrease  in  the  growth  or  cornification  of  the  vagina  was 
detected. 346  IMPEDED  ESTROGENS 
CONCLUSIONS 
Two  small  groups  of  steroids  in  the  estrane  series--here  designated  as 
impeded  estrogens,--represent  a  class  of compounds which  differ from  the 
majority of estrogenic substances  in  exerting  certain  unusual influences on 
growth of the uterus. The induction of these effects previously was considered 
to be peculiar to estriol. The unusual growth properties common to impeded 
estrogens  are  twofold:  (a)  after  the  threshold  dosage  required  to  initiate 
growth has been reached, the slope of the curve of increment of uterine weight 
in  response  to  increased steroid  dosage is  very gradual rather  than  steep; 
(b)  these  compounds possess  the  ability to  inhibit to  a  limited extent  the 
uterine  growth  induced  by estrone  administered concurrently. 
The partial inhibition of estrone-induced growth of the uterus is confined 
to a  critical dosage of the impeded estrogen and  is overcome by increased 
dosage of the inhibitor. Estrone-induced growth of the vagina is not inhibited 
by impeded estrogens.  Furthermore the  simultaneous administration of im- 
peded estrogens and testosterone does not lessen the amount of uterine growth 
evoked by the latter. 
The  impeded  estrogens  so  far  encountered  are  3-hydroxyestratriene de- 
rivatives possessing either a  ketone group at position 6 or a  hydroxyl group 
at position 16. Oxygenated functions at these positions in phenolic estrogens 
have special significance in the excitation and restraint of uterine growth un- 
shared by similar groups at certain other sites of the estrane molecule. 
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